BGBIO Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Bergenbio ASA - Alpha Spread
B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 9.07 NOK 1.06% Market Closed
Market Cap: 368.3m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Wall Street
Price Targets

BGBIO Price Targets Summary
Bergenbio ASA

Wall Street analysts forecast BGBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BGBIO is 31.28 NOK with a low forecast of 5.05 NOK and a high forecast of 73.5 NOK.

Lowest
Price Target
5.05 NOK
44% Downside
Average
Price Target
31.28 NOK
245% Upside
Highest
Price Target
73.5 NOK
710% Upside
Bergenbio ASA Competitors:
Price Targets
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
188% Upside
302440
SK Bioscience Co Ltd
11% Downside
PHM
Pharma Mar SA
14% Upside
300439
MedicalSystem Biotechnology Co Ltd
168% Upside
PTCT
PTC Therapeutics Inc
6% Upside
4593
Healios KK
28% Upside
HPHA
Heidelberg Pharma AG
390% Upside
AUTL
Autolus Therapeutics PLC
176% Upside

Revenue
Forecast

Revenue Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BGBIO's stock price target?
Price Target
31.28 NOK

According to Wall Street analysts, the average 1-year price target for BGBIO is 31.28 NOK with a low forecast of 5.05 NOK and a high forecast of 73.5 NOK.

Back to Top